Stille AB (OM:STIL) acquired Fehling Instruments Gmbh & Co. Kg and Fehling Verwaltungs Gmbh.
January 24, 2024
Share
Stille AB (OM:STIL) entered into an agreement to acquire Fehling Instruments Gmbh & Co. Kg and Fehling Verwaltungs Gmbh for ?36 million on November 29, 2023. The transaction is on cash free and debt free basis and will be funded through cash. The acquisition is conditional upon the Stille AB receiving sufficient financing to carry out the acquisition and the Stille AB board of directors thus intends to resolve on a directed issue of shares subject to the general meeting's subsequent approval. Stille intends to conduct a directed share issue to institutional investors with deviation from the shareholders? pre-emption rights to finance the consideration. Fehling reported sales of ?15.8 million and adjusted EBITDA of approximately ?4.8 million for the year ended 2022. The transaction is expected to close at the end of January 2024. Evli Corporate Finance AB acted as financial advisor to Stille AB (OM:STIL). Kristina Schneider, Katharina Prasuhn, Ann-Kathrin Jungen, Meike Daniels, Michael KA¶mpel, Lutz Martin Keppeler, Markus Lennartz, Manuel Poncza, Ruben Schneider, Christoph Schork, Henrik Lay, Tim Petermann, Catarina Angelika Seemann,Kim Anna Schwick, Alexander Bork, Mathis Dick, Marcel Maybaum,, Astrid Luedtke, Beatrice Stange, Wolfram Meven and Michael Kreisler of Heuking Kühn Lüer Wojtek acted as legal advisor to Stille AB.
Stille AB (OM:STIL) acquired Fehling Instruments Gmbh & Co. Kg and Fehling Verwaltungs Gmbh on January 25, 2024.
Stille AB is a Sweden-based company engaged in the development, manufacture, and marketing of technical medical equipment. The product portfolio is divided into two business lines. The Surgery business area develops, produces and markets handcrafted, forged surgical instruments for all fields of open surgery, with an emphasis on cardiovascular surgery, and reconstructive and aesthetic plastic surgery. Its products include scissors, forceps, artery forceps, needle holders and clamps, among others. The Patient Positioning area develops and manufactures two main groups of procedure-specific specialized tables for cardiovascular surgery and gynecology, urology and urodynamic examinations. As of December 31, 2011, the Company had two wholly owned subsidiaries, Stille Surgical Inc. and Stille Incentive AB. As of December 30, 2011, the it's largest shareholder was Linc Invest AB (39.81%). On September 2, 2013, the Company sold its business unit, Sonesta, to ADDvise Lab Solutions publ AB.